You are viewing the site in preview mode
Skip to main content
|
Parameter
|
Value
|
|---|
|
Sex
| |
|
Male
|
70 (82.35)
|
|
Female
|
15 (17.65)
|
|
Hepatitis B
| |
|
Positive
|
56 (65.88)
|
|
Negative
|
29 (34.12)
|
|
Tumour number
| |
|
Single
|
65 (76.47)
|
|
Multiple
|
20 (23.53)
|
|
Preoperative parameters
| |
|
Age (year)
|
44.71 ± 11.52
|
|
Platelet count (109/L)
|
261.43 ± 85.68
|
|
Total bilirubin (μmol/l)
|
15.51 ± 11.87
|
|
Albumin (g/L)
|
39.05 ± 4.50
|
|
ALT (IU/L)
|
45.53 ± 26.09
|
|
AST (IU/L)
|
78.16 ± 62.08
|
|
Prothrombin time (s)
|
12.86 ± 1.21
|
|
Alpha-foetoprotein (μg/ml)
|
770.57 ± 1060.93
|
|
Body surface area (m2)
|
1.95 ± 0.16
|
|
Tumour size (cm)
|
11.37 ± 3.69
|
|
Remnant liver volume (ml)
|
552.18 ± 214.32
|
|
SRLV (ml/m2)
|
282.00 ± 96.20
|
|
Child–Pugh classification
| |
|
A
|
71 (83.53)
|
|
B
|
14 (16.47)
|
|
Intraoperative parameters
| |
|
Blood loss (ml)
|
716.67 ± 650.96
|
|
Postoperative parameters
| |
|
Tumour capsule
| |
|
Yes
|
75 (88.24)
|
|
No
|
10 (11.76)
|
|
Macrovascular invasion
| |
|
Yes
|
64 (75.29)
|
|
No
|
21 (24.71)
|
|
Hepatic fibrosis stage
| |
|
No significant fibrosis
|
31 (36.47)
|
|
Severe fibrosis
|
24 (28.24)
|
|
Cirrhosis
|
30 (35.29)
|
|
Hospital stay (days)
|
25.87 ± 6.56
|
- Values are n (%) or mean ± SD
- ALP alkaline phosphatase, ALT alanine transaminase, AST aspartate aminotransferase, SRLV standard remnant liver volume
